XT
KPRX icon

XTX Topco’s Kiora Pharmaceuticals KPRX Stock Holding History

XTX Topco’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.4K Buy
14,719
+2,748
+23% +$5.8K ﹤0.01% 3471
2025
Q4 		$23.6K Buy
+11,971
New +$27.3K ﹤0.01% 3025
2024
Q2 		– Sell
-2,768
Closed -$17.6K – 2179
2024
Q1 		$17.6K Buy
+2,768
New +$15.5K ﹤0.01% 1623
2023
Q4 		– Sell
-1,310
Closed -$6.94K – 1856
2023
Q3 		$6.94K Buy
+1,310
New +$6.71K ﹤0.01% 1448
2021
Q4 		– Sell
-39
Closed -$31K – 847
2021
Q3 		$31K Buy
+39
New +$33.1K 0.01% 630

Other funds holding KPRX

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

XTX Topco's KPRX Position: Q1 2026 in Review

XTX Topco increased its Kiora Pharmaceuticals (KPRX) stake by 23% in Q1 2026, buying an estimated $5.8K and bringing the position to 14,719 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

XTX Topco first reported a position in KPRX in Q3 2021 and has held it in 5 quarters since. The position peaked at $31K in Q3 2021. 18 funds tracked by Wall St. Rank hold KPRX as of Q1 2026.

  • XTX Topco held 14,719 shares of Kiora Pharmaceuticals worth $28.4K as of Q1 2026.
  • XTX Topco bought 2,748 Kiora Pharmaceuticals shares in Q1 2026, an estimated $5.8K.
  • Kiora Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3471 holding.
  • XTX Topco first reported a position in Kiora Pharmaceuticals in Q3 2021 and has held it in 5 quarters since.
  • XTX Topco's Kiora Pharmaceuticals position peaked at $31K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.